Report – “New 0604 PTHC”
Final Version
| Milestone | Target Date | Owner | Deliverable | |-----------|-------------|-------|-------------| | Final sign‑off on SOPs | 15 Apr 2026 | Vanessa | SOP package (PDF) | | System go‑live (all sites) | 1 May 2026 | Vanessa | Live EHR integration | | Staff training completion | 31 May 2026 | Vanessa | Training attendance logs | | First KPI review | 30 Jun 2026 | Valya | KPI report | | Model recalibration (12 mo) | 30 May 2027 | Laura | Updated model version | | Expansion feasibility study | Q3 2027 | Irisa | Feasibility report | New 0604 Pthc Valya Irisa Laura Vanessafinal Version
| In‑Scope | • Adult oncology patients (solid tumours)
• Baseline labs, imaging, functional status
• Integration with existing EHR (Epic) |
|--------------|---------------------------------------------------|
| Out‑of‑Scope | • Paediatric oncology
• Non‑oncology pathways |
| Primary Objectives | 1. Develop a risk‑stratification model (low/medium/high).
2. Embed the model into the clinical workflow.
3. Produce real‑time dashboards for monitoring. |
| Secondary Objectives | 1. Create SOPs and training material.
2. Conduct a cost‑benefit analysis. | Report – “New 0604 PTHC”
Final Version
| Context | Rising variability in pre‑treatment assessment leads to delayed therapy initiation, sub‑optimal patient selection, and increased adverse‑event rates. |
|------------|------------------------------------------------------------------------------------------------------------------------|
| Problem | No unified, evidence‑based health‑check that aligns oncologists, radiologists, and nursing staff across sites. |
| Purpose | Build a standardised, scalable, and predictive health‑check that:
• Identifies high‑risk patients early
• Reduces unnecessary investigations
• Improves time‑to‑treatment by ≥ 15 %
• Enhances patient satisfaction scores (> 4.5/5). | sub‑optimal patient selection
The title "New 0604 Pthc Valya Irisa Laura Vanessafinal Version" seems to suggest a few key points: